Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

This study has been completed.
Pharmacia and Upjohn
Information provided by (Responsible Party):
Miguel Villalona, Ohio State University Comprehensive Cancer Center Identifier:
First received: September 12, 2005
Last updated: December 18, 2012
Last verified: December 2012